Back
#1
27.0%
Top 0.1%
21.5%
Top 0.5%
10.9%
Top 69%
7.2%
Top 28%
6.1%
Top 75%
2.4%
Top 6%
2.4%
Top 38%
1.9%
Top 7%
1.6%
Top 15%
1.4%
Top 20%
0.9%
Top 8%
0.9%
Top 12%
0.9%
Top 30%
0.9%
Top 4%
0.6%
Top 27%
0.6%
Top 16%
0.6%
Risk-stratified monitoring for sulfasalazine toxicity: prognostic model development and validation.
2023-12-18
rheumatology
Title + abstract only
View on medRxiv
Show abstract
BackgroundSulfasalazine induced cytopenia, nephrotoxicity, and hepatotoxicity is uncommon during long-term treatment. Some guidelines recommend three monthly monitoring blood-tests indefinitely while others recommend stopping monitoring after one year. To rationalise monitoring we developed and validated a prognostic model for clinically significant blood, liver, or kidney toxicity during established sulfasalazine treatment. DesignRetrospective cohort study. SettingUK primary-care. Data from C...
Predicted journal destinations
1
Rheumatology
21 training papers
2
Annals of the Rheumatic Diseases
23 training papers
3
Arthritis & Rheumatology
21 training papers
4
PLOS ONE
1737 training papers
5
BMJ Open
553 training papers
6
Scientific Reports
701 training papers
7
Frontiers in Medicine
99 training papers
8
Nature Communications
483 training papers
9
Frontiers in Immunology
140 training papers
10
JAMA Network Open
125 training papers
11
Journal of Clinical Medicine
77 training papers
12
JCI Insight
63 training papers
13
Vaccines
131 training papers
14
BMC Medicine
155 training papers
15
Journal of Clinical Epidemiology
29 training papers
16
PLOS Medicine
95 training papers
17
eBioMedicine
82 training papers